Faculty home

Pharmacy and Pharmaceutical Sciences

Only through community and collaboration can we achieve the best possible results. Together we aim to shift gears and change old ways of thinking. And we need people like you – your skills, your perspectives, your passion.

Stay up-to-date with the latest news from inside the world of Pharmacy and Pharmaceutical Sciences.

Starpharma logo

MIPS partner, Starpharma, announces positive phase 1 clinical results for DEP® Docetaxel

11 October 2017

Scientists within Professor Chris Porter’s group at the ARC Centre of Excellence for Convergent Bio-Nano Science and Technology at the Monash Institute of Pharmaceutical Science have been working for a number of years with the Australian Biotechnology company, Starpharma, to develop advanced drug delivery systems. One result of those programs has been the development of the DEP® delivery platform with broad application including for improved cancer treatments. The DEP® delivery technology, based on Starpharma’s star-shaped polymers or dendrimers, has been shown to improve drug efficacy and reduce toxicity in a number of pre-clinical oncology models.  Starpharma has applied this technology in its own development programs (such as DEP® docetaxel) and in partnership with pharmaceutical companies, for example AstraZeneca (see http://starpharma.com/news/340).

MMIC Advisory Board to help Victorian Manufacturing Innovate

Medicine Manufacturing

10 October 2017

Monash University’s Medicines Manufacturing Innovation Centre (MMIC) announced the members of its Industry Advisory Board. Following the announcement an expert panel asked if pharmaceutical manufacturing is keeping pace with the advances of 21st century medicine. The event was hosted by the BioMelbourne Network.

Rethink on beta blockers for heart attack survivors who take their other heart medication

20 September 2017

Beta blockers were found to offer no additional survival benefit for heart attack survivors who take two other medicines as prescribed, according to a new study involving Monash University’s Centre for Medicine Use and Safety.

Honorary doctorate conferred to ground-breaking biological scientist, Jean-Pierre Changeux

19 September 2017

Jean-Pierre Changeux, one of the world’s most eminent biological scientists, will receive the highest accolade from Monash University, an Honorary Doctorate (Doctor of Laws; Honoris Causa).

Professor William Charman

Professor William Charman receives Honorary Fellowship of the Royal Pharmaceutical Society

13 September 2017

Professor William Charman, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, has been made an Honorary Fellow of the Royal Pharmaceutical Society (RPS). The Honorary Fellowship was bestowed at a Royal Pharmaceutical Society event at the International Pharmaceutical Federation (FIP) world congress in South Korea last night.

View more articles